# Novo Nordisk a S: Form 6-K, filed Mar 20, 2026

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 6-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 08:11 ET
- Period: 2026-03-19
- Accession: 0001171843-26-001813
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000117184326001813/f6k_031926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000117184326001813/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000117184326001813/f6k_031926.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-001813. Last ingested by Listed: Nov 9, 2026, 17:51 ET. No prices; not investment advice.
